News | Women's Health | July 21, 2015

Study Examines "The Angelina Jolie Effect" on Breast Cancer Screening

North Carolina State University researcher finds celebrity influence had major impact on screening decisions, even above family history

breast cancer screening, Angelina Jolie, Kami Kosenko, North Carolina State

July 21, 2015 Angelina Jolie received widespread media attention in 2013 when she told the public that she'd tested positive for BRCA1, a gene associated with an increased risk of breast and ovarian cancers. Now research shows that this publicity did influence some women's intentions to seek out similar genetic testing.

"We put a questionnaire online within three days of Jolie's announcement, to see if the announcement influenced anyone's intention to get genetic testing," said Kami Kosenko, an associate professor of communication at North Carolina State University and lead author of a paper on the work. "We also wanted to see if there were any variables, such as whether people felt they identified with Jolie, that were associated with people who were influenced by Jolie's announcement."

Three hundred and fifty-six people from across the United States completed the questionnaire, of which 295 were aware of Jolie's announcement and double mastectomy.

Of the 229 female study participants, researchers found that 30 percent intended to get tested to see if they carried the BRCA1 gene, with 23 percent saying they would probably get tested and 7 percent saying they would definitely get tested.

"Women who identified more strongly with Jolie were more likely to intend to get the genetic testing regardless of whether they had a family history of cancer than women who did have a family history of cancer but did not identify with Jolie," Kosenko said. "The same was true of women who felt they had some sort of parasocial relationship with Jolie, meaning they viewed her as a friend. This means that Jolie's speaking out definitely had an impact."

The findings suggest that when it comes to a celebrity's impact on the public, that impact depends in part on the extent to which the public identifies with the celebrity. In other words, there appears to be something about particular celebrities that engenders more public interest and concern.

"This indicates that health practitioners and advocates may want to consider how relatable a celebrity is with the target audience when searching for a celebrity spokesperson," Kosenko said. "However, more work needs to be done to help us understand what makes a celebrity relatable. For example, in our survey, non-white women were more likely to identify with Jolie than white women were. Why is that? We don't know."

The paper, "Celebrity Influence and Identification: A Test of the Angelina Effect," was published online in the Journal of Health Communication.

For more information: www.ncsu.edu

Related Content

Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...
Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital.

Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital. Image courtesy of Saarland University/Thorsten Mohr

 

News | Prostate Cancer | January 13, 2020
January 13, 2020 — When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewha
The study found that DBN laws helped some women understand they had increased breast density, but not that breast density is associated with a higher risk of breast cancer or that dense breasts limit the ability of mammograms to detect cancer
News | Breast Density | January 09, 2020
January 9, 2020 — A new study suggests that state-mandated notifications on...
Sponsored Content | Videos | Digital Radiography (DR) | January 03, 2020
At RSNA19, David Widmann, president and CEO of Konica Minolta Healthcare Americas, discussed innovation, stressing th
prostate cancer UCL study
News | Prostate Cancer | January 03, 2020
January 3, 2020 — Nearly one in six deaths from...